Case Report: Pathologic Complete Response to Induction Therapy in a Patient With Potentially Resectable Pancreatic Cancer

Immune monotherapy does not appear to work in patients with pancreatic cancer so far. We are conducting a clinical trial that combines programmed cell death protein-1 (PD-1) inhibitor with chemotherapy and concurrent radiotherapy as induction therapy for patients with locally advanced pancreatic can...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Changchang, Zhu, Yahui, Cheng, Hao, Kong, Weiwei, Zhu, Linxi, Wang, Lei, Tang, Min, Chen, Jun, Li, Qi, He, Jian, Li, Aimei, Qiu, Xin, Chen, Dongsheng, Meng, Fanyan, Qian, Xiaoping, Liu, Baorui, Qiu, Yudong, Du, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207502/
https://www.ncbi.nlm.nih.gov/pubmed/35734594
http://dx.doi.org/10.3389/fonc.2022.898119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207502/
https://www.ncbi.nlm.nih.gov/pubmed/35734594
http://dx.doi.org/10.3389/fonc.2022.898119

Ejemplares similares